20 (AIDX) Total Current Liabilities (2024 - 2026)

20's (AIDX) quarterly Total Current Liabilities came in at $2.6 million in Q1 2026, up 4.75% on a QoQ basis from $2.5 million in Q4 2025.

20 (AIDX) Total Current Liabilities (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Total Current Liabilities data on file, last reported at $2.6 million in Q1 2026.

Quarterly Total Current Liabilities changed N/A year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (changed N/A YoY) and the FY2025 annual result came in at $2.5 million, up 81.77% from the prior year.
Total Current Liabilities grew to $2.6 million in Q1 2026, from $2.5 million in the prior quarter.
In the past five years, Total Current Liabilities ranged from a high of $2.6 million in Q1 2026 to a low of $1.4 million in Q4 2024.
A 3-year average of $2.1 million and a median of $2.5 million in 2025 frame the typical range for Total Current Liabilities.
The widest YoY moves for Total Current Liabilities: up 81.77% in 2025, down 81.77% in 2025.
Tracing AIDX's Total Current Liabilities over 3 years: stood at $1.4 million in 2024, then soared by 81.77% to $2.5 million in 2025, then increased by 4.75% to $2.6 million in 2026.
The last three Total Current Liabilities figures came in at $2.6 million (Q1 2026), $2.5 million (Q4 2025), and $1.4 million (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Current Liabilities (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	17.81 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	6.68 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	11.66 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	6.43 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	1.51 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	2.36 Bn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	8.30 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	8.63 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	1.28 Bn
10	20	5.55 Mn	1.00 Mn	304,727.00	2.55 Mn

Download Data